期刊文献+

糖尿病肾病尿毒症患者血管钙化其及危险因素分析 被引量:11

Cardiovascular calcification in diabetic nephropathy patients in uremic stage and analysis on its risk factors
下载PDF
导出
摘要 目的:观察尿毒症患者动脉血管钙化情况及危险因素,探讨糖尿病对尿毒症血管钙化的影响。方法:选取初次诊断为尿毒症的未透析患者,按照其原发病分为糖尿病肾病(DN)组和非糖尿病肾病(NDN)组。随机选取该院同期体检中心年龄、性别匹配的健康人作为对照组。行双手及腕关节正位、腹侧位及髋关节正位X线平片检查,并按照X线平片血管钙化程度对各部位积分累加计算总分;双能X线骨密度仪测定患者股骨颈骨密度;检测患者甲状旁腺激素(iPTH)、肝肾功能、Ca、P、SCr等生化指标,计算矫正Ca值及Ca×P。对各参数的相互关系进行统计学分析。结果:①尿毒症患者39例,其中DN组患者20例(51.28%),其糖尿病患病时间为(8.11±7.39)年;NDN组患者19例(48.72%);对照组20例。②39例尿毒症患者中有29例(74.36%)存在动脉血管钙化,其中血管钙化总积分1~3分23例(58.97%),3~6分6例(15.38%);对照组未见血管钙化。骨密度测量显示39例患者中骨量减少者14例(35.90%),股骨颈骨密度T值为-0.81±0.87;矫正Ca值为(2.01±0.43)mmol·L-1;血清磷(2.08±0.49)mmol·L-1;Ca×P(49.94±9.54)mg2·dL-2。③线性相关分析显示:尿毒症血管钙化程度与血清矫正Ca值及血磷水平相关(r=0.026,P<0.05;r=-0.639,P<0.05),与骨密度无相关性(P>0.05);与糖尿病患病时间呈显著正相关(r=0.790,P<0.001)。Logistic回归分析显示:随着糖尿病患病时间的延长尿毒症患者血管钙化程度加重,糖尿病患病时间是尿毒症患者血管钙化程度的独立危险因素(P<0.05),患者矫正Ca值及血磷水平对血管钙化程度的影响被剔除(P>0.05)。④DN组血管钙化发生率(95.0%)高于NDN组(42.1%,P<0.05);DN组血管钙化积分(3.18±1.77)高于NDN组(1.56±0.97,P<0.05)。结论:与非糖尿病肾病尿毒症患者相比,糖尿病肾病血管钙化的发生率和程度显著增高,糖尿病患病时间是尿毒症患者血管钙化的独立危险因素,早期积极干预高血糖可能有助于控制糖尿病肾病尿毒症患者血管钙化。 Objective To investigate the prevalence of arterial vascular calcification (VC)in uremic patients undergoing diabetic nephropathy(DN)and explore its risk factors.Methods Demographic and clinical data were collected in the patients latest diagnosed as uremia and not received dialysis treatment.The uremic patients were divided into DN group and non-diabetic nephropathy(NDN)group.And 20healthy subjects were chosen as control group from the Physical Examination Room.The patients'sex and ages were similar in the 3groups.VC was semi-quantitatively evaluated by plain radiographic films from abdomen,pelvis and hands.The clinical and laboratorial parameters related to VC were detected and analyzed.Results ①The present study included 20 (51.28%)DN uremic patients and 19 (48.72%)NDN uremic patients.The average diabetic duration in the DN patients was (8.11±7.39)years.②Among the 39uremic patients,VC was found on radiographic films in 29cases(74.36%),including 23cases(58.97%)with the con-score 1-3and 6cases(15.38%)with 3-6scores.And VC was not detected in control group.Bone density analysis showed that osteopenia occupied 14cases(35.90%)in all and the T-score was-0.81±0.87.③Linear correlation analysis revealed that VC was correlated with serum calcium and phosphate(r=0.026,P〈0.05;r=-0.639,P〈0.05),and uncorrelated with bone density (P〉0.05).VC score was significantly correlated with the diabetic duration (r=0.790,P〈0.001).Logistic regression revealed that the diabetes duration was the independent risk factors(P〈0.05)for VC.The reflections of serum calcium and phosphate were rejected.④The prevalence of VC in DN gourp(95.0%)was higher than that in NDN group (42.1%,P〈0.05).And the VC score in DN group(3.18±1.77)was higher than that in NDN group(1.56± 0.97,P〈0.05).Conclusion There is a higher VC prevalence rate and more VC severity in DN uremic patients than in NDN patients.Diabetes duration is an independent risk factor for VC.Preventing from the high serum glucose maybe plays an effective role in controlling the VC in diabetic nephropathy patients in uremic stage.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2010年第5期946-951,共6页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(30800529)
关键词 血管钙化 糖尿病肾病 尿毒症 vascular calcification diabetic nephropathy uremia
  • 相关文献

参考文献12

  • 1闫铁昆,林珊,贾俊亚,商文雅,韦丽.尿毒症患者桡动脉盐皮质激素受体表达与血管钙化的关系[J].中华肾脏病杂志,2010,26(3):181-186. 被引量:12
  • 2London GM, Guefin AP, Marchais SJ, et aI. Arterial media calcification in end stage renal, disease: impact on all cause and cardiovascular mortality [J].Nephrol Dial Transplant, 2003, 18 (9): 1731- 1740.
  • 3Go AS, Chertow GM, Fan D, et al, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J]. N Engl J Med, 2004, 35 (1):1296-1305.
  • 4Adragao T, Pires A, Lucas C, et al. A simple vascular calcification score predicts cardiovascuar risk in hemodialysis patients [J]. Nephrol Dial Transplant, 2004, 19 (5): 1480- 1488.
  • 5Oh J, Wunsch R, Turzer M, et al. Coranary advanced carotid arteriopathy in young adults with childhood-onset chronic renal failure[J]. Circulation, 2002, 106 (1): 100- 105.
  • 6Moe SM, Chen NX. Inflammation and vascular calcification [J].Blood Purif, 2005, 23 (1): 64- 71.
  • 7韦洮,王梅,甘良英,王宓,李欣,赵青艺,檀敏.血液透析患者血管钙化、骨密度与骨保护素及其配体的相互关系[J].中华肾脏病杂志,2008,24(7):456-460. 被引量:5
  • 8Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular morality for a long term peritoneal dialysis patients: a prospective study [J]. J Am Soc Nephrol, 2008, 14 (1): 159-168.
  • 9Raggi P, Bellasi A, Ferramosca E, et al. Association of Pulse wave velocity with vascular and valvular calcification in hemodialysis patients [J]. Kidney Int, 2007, 71 (8): 802-807.
  • 10Hernandez JD, Wesseling K, Pereira R, et al. Technical approach to iliac crest biopsy [J]. Clin J Am Soc Nephrol,2008, 3 (Suppl3): S164-169.

二级参考文献30

  • 1张萍,陈江华,蒋华,王慧萍,金娟.尿毒症患者血管中膜钙化和骨特异性蛋白的表达[J].中华肾脏病杂志,2005,21(2):69-71. 被引量:11
  • 2余卫,秦明伟,徐苓,田均平,邢小平,孟迅吾,曹坚,严洪珍,葛秦生.正常人腰椎骨密度变化(附445例双能X线骨密度仪测量分析)[J].中华放射学杂志,1996,30(9):625-629. 被引量:57
  • 3Michael J,Mazzini P,Christiart S. Proalherogenic pathways leading to vascular calcification. J Euro Radiol, 2006,57: 384-389.
  • 4Adragao T,Pires A,Lucas C,et al. A simple vascular ealcification score predicls cardiovascular risk in hemodialysis patients. Nephrol Dial Transplant, 2004,19: 1480-1488.
  • 5World Health Organ. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. Techn Rep Ser, 1994,843:1-129.
  • 6Tsuda E, Coto M, Mochizuki S, et al. Isolation of a novel cytokine form human fibroblasts that specifically inhibits osteoclastogenesia. Bioche Biophys Res Commun, 1997,234: 137-142.
  • 7Khosla S. Minireview: The OPG/RANKL/RANK system. Endocrinology, 2001,142:5050-5055.
  • 8Lam J, Nelson CA, Ross FP, et al. Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptorligand specificity. J Clin Invest, 2001,108:971-979.
  • 9Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin deficient mice develop early onsetosteoprosis and arterial calcification. Genes Dev, 1998,12:1260-1268.
  • 10Crisafulli A, Romeo A, Floccari F, et al. Osteoprotegerin and bone mineral density in hemodiafihration patients. Ren Fail, 2005,27:531-539.

共引文献15

同被引文献85

  • 1生杰,赵久阳.慢性肾脏病患者钙磷代谢紊乱与心瓣膜钙化[J].中国血液净化,2012,11(2):99-101. 被引量:13
  • 2向茜,郭燕,李万碧,张弦,张永新,杨才,蔡艳,刘乒乒.糖尿病肾病患者血管钙化特点分析[J].慢性病学杂志,2013,13(2):104-108. 被引量:2
  • 3马文琦,刘乃丰.糖尿病与血管钙化的基础与临床[J].中国动脉硬化杂志,2015,23(5):453-457. 被引量:10
  • 4王宓,左力.糖尿病与血管钙化[J].中国动脉硬化杂志,2015,23(5):458-463. 被引量:6
  • 5AVaziri ND, Pahl MV, Crum A, et al. Effect of uremia on structure and function of immune system. J Ren Nutr, 2012, 22 ( 1 ) : 149-156.
  • 6Walkowiak B, Sobol AB, Walczynska M, et al. Effect of Uremia and Hemodialysis on Proteome Profile of Blood Platelets and Plas- ma. Clin Appl Thromb Hemost, 2012,24(06) :331-337.
  • 7Dikow R, Schmidt U, Kihm LP, et al. Uremia aggravates left ven- tricular remodeling after myocardial infarction. Am J Nephro1,2010, 32(1) : 13-22.
  • 8Glorieux G, Cohen G, Jankowski J, et al. Platelet/Leukocyte acti- vation, inflammation, and uremia. Semin Dial, 2009, 22 ( 4 ) : 423 -427.
  • 9Vaziri ND, Yuan J, Rahimi A, et al. Disintegration of colonic ep- ithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant ,2012,27 (7) :2686-2893.
  • 10Cozzalion M,Brancaccio D,GallieniM,et al.Pathogenesis of vascular calcification in chronic kidney disease [J]. kidney international. 2005;68(2) 429-36.

引证文献11

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部